company background image
IDX logo

Integral Diagnostics ASX:IDX Stok Raporu

Son Fiyat

AU$3.02

Piyasa Değeri

AU$706.4m

7D

1.7%

1Y

9.4%

Güncellenmiş

03 Oct, 2024

Veri

Şirket Finansalları +

Integral Diagnostics Limited

ASX:IDX Stok Raporu

Piyasa değeri: AU$706.4m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

IDX Stoklara Genel Bakış

Bir sağlık hizmetleri şirketi olan Integral Diagnostics Limited, Avustralya ve Yeni Zelanda'daki pratisyen hekimlere, tıp uzmanlarına ve yardımcı sağlık profesyonellerine ve hastalarına tanısal görüntüleme hizmetleri sunmaktadır.

Integral Diagnostics Limited Rakipler

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Integral Diagnostics
Tarihsel hisse senedi fiyatları
Güncel Hisse FiyatıAU$3.02
52 Haftanın En Yüksek SeviyesiAU$3.06
52 Haftanın En Düşük SeviyesiAU$1.64
Beta0.73
11 Aylık Değişim16.60%
3 Aylık Değişim15.71%
1 Yıllık Değişim9.42%
33 Yıllık Değişim-38.11%
5 Yıllık Değişim-3.51%
Halka arzdan bu yana değişim65.03%

Son Haberler & Güncellemeler

Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital

Feb 21
Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital

Recent updates

Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital

Feb 21
Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital

Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being

Nov 22
Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being

Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year

Feb 20
Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year

These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively

Dec 14
These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively

Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?

May 26
Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?

Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year

Feb 28
Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year

Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate

Feb 25
Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate

Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why

Oct 29
Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why

Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?

Sep 13
Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?

An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued

Jun 04
An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued

Should You Be Adding Integral Diagnostics (ASX:IDX) To Your Watchlist Today?

May 14
Should You Be Adding Integral Diagnostics (ASX:IDX) To Your Watchlist Today?

Is Integral Diagnostics Limited (ASX:IDX) A Smart Choice For Dividend Investors?

May 03
Is Integral Diagnostics Limited (ASX:IDX) A Smart Choice For Dividend Investors?

We Think Integral Diagnostics (ASX:IDX) Can Stay On Top Of Its Debt

Apr 16
We Think Integral Diagnostics (ASX:IDX) Can Stay On Top Of Its Debt

Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?

Mar 27
Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?

Is Integral Diagnostics Limited's (ASX:IDX) Stock's Recent Performance A Reflection Of Its Financial Health?

Mar 17
Is Integral Diagnostics Limited's (ASX:IDX) Stock's Recent Performance A Reflection Of Its Financial Health?

The Trends At Integral Diagnostics (ASX:IDX) That You Should Know About

Mar 07
The Trends At Integral Diagnostics (ASX:IDX) That You Should Know About

Here's What We Like About Integral Diagnostics' (ASX:IDX) Upcoming Dividend

Feb 25
Here's What We Like About Integral Diagnostics' (ASX:IDX) Upcoming Dividend

Is Integral Diagnostics Limited (ASX:IDX) Popular Amongst Institutions?

Feb 23
Is Integral Diagnostics Limited (ASX:IDX) Popular Amongst Institutions?

Have Insiders Been Selling Integral Diagnostics Limited (ASX:IDX) Shares?

Feb 13
Have Insiders Been Selling Integral Diagnostics Limited (ASX:IDX) Shares?

Integral Diagnostics Limited's (ASX:IDX) Intrinsic Value Is Potentially 46% Above Its Share Price

Feb 03
Integral Diagnostics Limited's (ASX:IDX) Intrinsic Value Is Potentially 46% Above Its Share Price

Here's What We Learned About The CEO Pay At Integral Diagnostics Limited (ASX:IDX)

Jan 24
Here's What We Learned About The CEO Pay At Integral Diagnostics Limited (ASX:IDX)

Should You Use Integral Diagnostics's (ASX:IDX) Statutory Earnings To Analyse It?

Jan 14
Should You Use Integral Diagnostics's (ASX:IDX) Statutory Earnings To Analyse It?

Shareholders Of Integral Diagnostics (ASX:IDX) Must Be Happy With Their 201% Total Return

Jan 05
Shareholders Of Integral Diagnostics (ASX:IDX) Must Be Happy With Their 201% Total Return

Is Integral Diagnostics (ASX:IDX) A Risky Investment?

Dec 26
Is Integral Diagnostics (ASX:IDX) A Risky Investment?

At AU$4.30, Is It Time To Put Integral Diagnostics Limited (ASX:IDX) On Your Watch List?

Dec 17
At AU$4.30, Is It Time To Put Integral Diagnostics Limited (ASX:IDX) On Your Watch List?

What To Know Before Buying Integral Diagnostics Limited (ASX:IDX) For Its Dividend

Dec 08
What To Know Before Buying Integral Diagnostics Limited (ASX:IDX) For Its Dividend

Returns On Capital At Integral Diagnostics (ASX:IDX) Paint An Interesting Picture

Nov 29
Returns On Capital At Integral Diagnostics (ASX:IDX) Paint An Interesting Picture

Is Integral Diagnostics Limited's (ASX:IDX) Shareholder Ownership Skewed Towards Insiders?

Nov 19
Is Integral Diagnostics Limited's (ASX:IDX) Shareholder Ownership Skewed Towards Insiders?

Is Integral Diagnostics (ASX:IDX) A Risky Investment?

Sep 20
Is Integral Diagnostics (ASX:IDX) A Risky Investment?

Hissedar Getirileri

IDXAU HealthcareAU Pazar
7D1.7%3.8%1.1%
1Y9.4%-0.7%17.9%

Getiri vs. Endüstri: IDX geçen yıl % -0.7 oranında getiri sağlayan Australian Healthcare sektörünü aştı.

Getiri vs Piyasa: IDX geçen yıl % 17.9 oranında getiri sağlayan Australian Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is IDX's price volatile compared to industry and market?
IDX volatility
IDX Average Weekly Movement3.4%
Healthcare Industry Average Movement5.1%
Market Average Movement9.0%
10% most volatile stocks in AU Market17.6%
10% least volatile stocks in AU Market3.6%

İstikrarlı Hisse Senedi Fiyatı: IDX son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: IDX 'nin haftalık oynaklığı ( 3% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
19671,977Ian Kadishwww.integraldiagnostics.com.au

Bir sağlık hizmetleri şirketi olan Integral Diagnostics Limited, Avustralya ve Yeni Zelanda'da pratisyen hekimlere, tıp uzmanlarına ve yardımcı sağlık profesyonellerine ve hastalarına tanısal görüntüleme hizmetleri sunmaktadır. Pozitron emisyon tomografisi, manyetik rezonans görüntüleme ve diğer radyoloji hizmetleri sunmaktadır. Şirket 1967 yılında kurulmuştur ve merkezi Avustralya'nın Melbourne kentindedir.

Integral Diagnostics Limited Temel Bilgiler Özeti

Integral Diagnostics'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
IDX temel i̇stati̇sti̇kler
Piyasa değeriAU$706.43m
Kazançlar(TTM)-AU$60.70m
Gelir(TTM)AU$469.70m

1.5x

P/S Oranı

-11.6x

F/K Oranı

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
IDX gelir tablosu (TTM)
GelirAU$469.70m
Gelir MaliyetiAU$317.80m
Brüt KârAU$151.90m
Diğer GiderlerAU$212.60m
Kazançlar-AU$60.70m

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)-0.26
Brüt Marj32.34%
Net Kâr Marjı-12.92%
Borç/Özkaynak Oranı72.8%

IDX uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

1.9%

Mevcut Temettü Verimi

-22%

Ödeme Oranı